Cumberland Pharmaceuticals said this week that Dr. Robert Edwards will retire from its board of directors when his term expires next month.
Edwards, 86, has served on board of West End-based Cumberland since 1999, when the company was founded. Before that, he was chairman and managing director of a Therapeutic Antibodies subsidiary, overseeing operations in Australia, New Zealand and Southeast Asia. He also served as deputy director of the Institute for Medical & Veterinary Science in South Australia, and as the president of the Royal College of Pathologists of Australasia. Edwards received a Master of Human Physiology degree from London University and an M.D. from the University of Adelaide.
In its proxy statement, Cumberland said Edwards' successor as chair of the board's governance and nominating committee will be appointed from the board's seven remaining members at its April meeting. Edwards also is a member of the board's compensation committee.
Shares of Cumberland (Ticker: CPIX) closed Thursday trading at $4.55, down 1.1 percent on the day. Over the past three months, they have fallen 10 percent.
POSTDATA: WARRANTY DEEDS